Plaque is available for clinical use. The solution provides AI-powered coronary plaque analysis with detailed reporting - ...

Elucid’s PlaqueIQ is the first and only FDA-cleared plaque analysis software indicated for the carotid vasculature.

Cleerly, a leader in AI-based cardiovascular imaging, presented new, late-breaking science from the international CONFIRM2 ...

Elucid announced the launch of its PlaqueIQ image analysis software for the quantification and classification of plaque ...

Please provide your email address to receive an email when new articles are posted on . Alirocumab plus high-intensity statin therapy improved coronary plaque burden in patients with familial ...

Heart disease, a silent killer, stems from fatty plaque buildup in arteries. These plaques, composed of fats, cholesterol, ...

More than half of people living with HIV and suppressed viral loads nonetheless had imaging-confirmed coronary artery disease — and despite longtime use of HIV drugs that have been associated with ...

Which patients with a history of myocardial infarction (MI) are at risk of having another? The tools to predict risk for recurrent cardiac events in patients with established coronary artery disease ...

Please provide your email address to receive an email when new articles are posted on . The virus that causes COVID-19 may expedite progression of coronary lesions to high-risk plaque. SARS-CoV-2 was ...

OAK BROOK, Ill. - People living with human immunodeficiency virus (HIV) and without known cardiovascular disease have two to three times the noncalcified coronary plaque burden of non-HIV healthy ...

For many years, 2 axioms have ruled our thoughts and discussions of coronary atherosclerosis. The first axiom was that patients were at risk for acute coronary syndromes (ACS) if their coronary ...